Discover the eCTD v4.0 wave sweeping Japan and beyond. This blog outlines when major regions—Japan (PMDA), EU, US—are implementing eCTD v4.0, and highlights the benefits for pharma: faster approvals, global submission alignment, reusability, plus how to prepare effectively https://japan.freyrsolutions.com/blogs/japan-and-the-global-ectd-v4-0-wave-timelines-trends-readiness